SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001502146-10-000004
Filing Date
2010-10-21
Accepted
2010-10-21 10:48:17
Documents
1
Effectiveness Date
2010-10-21
Items
Item 06: Rule 506
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8389
  Complete submission text file 0001502146-10-000004.txt   9997
Mailing Address C/O GROSVENOR CAPITAL MANAGEMENT 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address ONE SANSOME ST 39TH FL. SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND II LP (Filer) CIK: 0001102444 (see all company filings)

IRS No.: 943341571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-123219 | Film No.: 101134369